Scisparc provides updates on status of spin-off of its advanced clinical stage pharmaceutical portfolio to a publicly traded company

According to the loi , scisparc's pharmaceuticals assets are valued at approximately us $11. 6 million
SPRC Ratings Summary
SPRC Quant Ranking